Disease | adenocarcinoma of esophagus |
Comorbidity | C0017168|oesophageal reflux |
Sentences | 6 |
PubMedID- 26269688 | Barrett's esophagus (be) is a precursor of esophageal adenocarcinoma and is associated with gastroesophageal reflux disease, which is often preceded by a hiatal hernia. |
PubMedID- 23735059 | Association of mdm2 t309g and p53 arg72pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma. |
PubMedID- 23225453 | Background: esophageal adenocarcinoma results from gastroesophageal reflux and develops along a sequence involving non-dysplastic barrett's esophagus (ndbe), low- (lgd) and high-grade dysplasia (hgd). |
PubMedID- 24282412 | Progression from healthy tissue to premalignant barrett's oesophagus (bo) and further to malignant oesophageal adenocarcinoma (oac) is associated with gastro-oesophageal reflux, leading to ros accumulation and increased oxidative dna damage. |
PubMedID- 24243140 | Siewert and leers have previously reported 37% 2 and 50% 3 respectively from large single centre western series compared to the low prevalence of type iii tumours seen in eastern series (5.6%) 29. the proportional increase in type i tumours in our series is likely to represent the widely reported increase in incidence of oesophageal adenocarcinoma 30,31 associated with gastro-oesophageal reflux disease 32 and barrett's metaplasia 33 in the united kingdom 34. the expansion of endoscopic barrett's surveillance strategies is also likely to have increased disease detection and treatment. |
PubMedID- 20955441 | Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. |
Page: 1